Compare AWF & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AWF | AMPH |
|---|---|---|
| Founded | 1993 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 864.9M | 971.8M |
| IPO Year | N/A | 2005 |
| Metric | AWF | AMPH |
|---|---|---|
| Price | $10.09 | $16.84 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $28.38 |
| AVG Volume (30 Days) | 513.4K | ★ 544.9K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 7.57% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | N/A | $6.90 |
| Revenue Next Year | N/A | $4.64 |
| P/E Ratio | ★ N/A | $124.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.85 | $17.03 |
| 52 Week High | $11.43 | $31.26 |
| Indicator | AWF | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 39.76 | 31.72 |
| Support Level | $9.99 | N/A |
| Resistance Level | $10.24 | $24.16 |
| Average True Range (ATR) | 0.11 | 0.86 |
| MACD | -0.03 | -0.62 |
| Stochastic Oscillator | 8.51 | 2.44 |
Alliancebernstein Glb High Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its primary investment objective is to seek high current income, and secondarily, capital appreciation. The fund invests in debt securities, including Sovereign Debt Obligations and corporate debt, denominated in non-U.S. currencies as well as in the U.S. Dollar. It may invest without limit in emerging and developed markets and debt securities of U.S. and non-U.S. corporate issuers.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.